Re: Seroxat ADR yellowcards =about 8 per 100,000 prescriptions

[Guest guest]

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

> > > > > >

> > > > > >

> > > > > >

> > > > > >

> > > > > > Suspected adverse drug reactions to paroxetine (yellow-card

> > reports)

> > > > > > per 100 000 paroxetine prescriptions by year and month

between

> > 2001

> > > > > > and 2004. Arrows indicate dates of Panorama programmes

(solid

> > arrows)

> > > > > > or regulatory communications (dashed arrows)

> > > > > >

> > > > > >

> > > > > > Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

> > > > > >

> > > > > > Published online 2005 October 27. doi:

> > 10.1111/j.1365-2125.2005.02527.

> > > > > >

> > > > > >

> > > > >

> > > >

> > > >

> > > >

> > > >

> > >

> >

> >

> >

> >

>

[Guest guest]

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

> > > > > >

> > > > > >

> > > > > >

> > > > > >

> > > > > > Suspected adverse drug reactions to paroxetine (yellow-card

> > reports)

> > > > > > per 100 000 paroxetine prescriptions by year and month

between

> > 2001

> > > > > > and 2004. Arrows indicate dates of Panorama programmes

(solid

> > arrows)

> > > > > > or regulatory communications (dashed arrows)

> > > > > >

> > > > > >

> > > > > > Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

> > > > > >

> > > > > > Published online 2005 October 27. doi:

> > 10.1111/j.1365-2125.2005.02527.

> > > > > >

> > > > > >

> > > > >

> > > >

> > > >

> > > >

> > > >

> > >

> >

> >

> >

> >

>

[Guest guest]

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

> > > > > >

> > > > > >

> > > > > >

> > > > > >

> > > > > > Suspected adverse drug reactions to paroxetine (yellow-card

> > reports)

> > > > > > per 100 000 paroxetine prescriptions by year and month

between

> > 2001

> > > > > > and 2004. Arrows indicate dates of Panorama programmes

(solid

> > arrows)

> > > > > > or regulatory communications (dashed arrows)

> > > > > >

> > > > > >

> > > > > > Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

> > > > > >

> > > > > > Published online 2005 October 27. doi:

> > 10.1111/j.1365-2125.2005.02527.

> > > > > >

> > > > > >

> > > > >

> > > >

> > > >

> > > >

> > > >

> > >

> >

> >

> >

> >

>

[Guest guest]

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

> > > > > >

> > > > > >

> > > > > >

> > > > > >

> > > > > > Suspected adverse drug reactions to paroxetine (yellow-card

> > reports)

> > > > > > per 100 000 paroxetine prescriptions by year and month

between

> > 2001

> > > > > > and 2004. Arrows indicate dates of Panorama programmes

(solid

> > arrows)

> > > > > > or regulatory communications (dashed arrows)

> > > > > >

> > > > > >

> > > > > > Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

> > > > > >

> > > > > > Published online 2005 October 27. doi:

> > 10.1111/j.1365-2125.2005.02527.

> > > > > >

> > > > > >

> > > > >

> > > >

> > > >

> > > >

> > > >

> > >

> >

> >

> >

> >

>

[Guest guest]

Hi ,

Yes, the drugs are a scourge on humanity!

Any bad press on the drugs is good for the public and reduces

prescriptions.

Any regulatory action against the drugs is also good for the public and

reduces prescriptions.

Sadly with more advertisment money spent then the original research and

development

we have an uphill battle to fight.

Is there direct to consumer advertising in England or Ireland?

In the US it's every other commercial and man do we have commercials.

Jim

On 2/5/2010 5:47 AM, jeremy9282 wrote:

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

Suspected adverse drug reactions to paroxetine (yellow-card

reports)

per 100 000 paroxetine prescriptions by year and month

between

2001

and 2004. Arrows indicate dates of Panorama programmes

(solid

arrows)

or regulatory communications (dashed arrows)

Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

Published online 2005 October 27. doi:

10.1111/j.1365-2125.2005.02527.

------------------------------------

[Guest guest]

Hi ,

Yes, the drugs are a scourge on humanity!

Any bad press on the drugs is good for the public and reduces

prescriptions.

Any regulatory action against the drugs is also good for the public and

reduces prescriptions.

Sadly with more advertisment money spent then the original research and

development

we have an uphill battle to fight.

Is there direct to consumer advertising in England or Ireland?

In the US it's every other commercial and man do we have commercials.

Jim

On 2/5/2010 5:47 AM, jeremy9282 wrote:

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

Suspected adverse drug reactions to paroxetine (yellow-card

reports)

per 100 000 paroxetine prescriptions by year and month

between

2001

and 2004. Arrows indicate dates of Panorama programmes

(solid

arrows)

or regulatory communications (dashed arrows)

Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

Published online 2005 October 27. doi:

10.1111/j.1365-2125.2005.02527.

------------------------------------

[Guest guest]

Hi ,

Yes, the drugs are a scourge on humanity!

Any bad press on the drugs is good for the public and reduces

prescriptions.

Any regulatory action against the drugs is also good for the public and

reduces prescriptions.

Sadly with more advertisment money spent then the original research and

development

we have an uphill battle to fight.

Is there direct to consumer advertising in England or Ireland?

In the US it's every other commercial and man do we have commercials.

Jim

On 2/5/2010 5:47 AM, jeremy9282 wrote:

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

Suspected adverse drug reactions to paroxetine (yellow-card

reports)

per 100 000 paroxetine prescriptions by year and month

between

2001

and 2004. Arrows indicate dates of Panorama programmes

(solid

arrows)

or regulatory communications (dashed arrows)

Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

Published online 2005 October 27. doi:

10.1111/j.1365-2125.2005.02527.

------------------------------------

[Guest guest]

Hi ,

Yes, the drugs are a scourge on humanity!

Any bad press on the drugs is good for the public and reduces

prescriptions.

Any regulatory action against the drugs is also good for the public and

reduces prescriptions.

Sadly with more advertisment money spent then the original research and

development

we have an uphill battle to fight.

Is there direct to consumer advertising in England or Ireland?

In the US it's every other commercial and man do we have commercials.

Jim

On 2/5/2010 5:47 AM, jeremy9282 wrote:

HI jim

As you say it is only over a couple of years & does center round the

years of the 4 or so Panorama programmes.

I wonder if anyone has taken the entire totals of drug reactions over a

drug marketing life & divided them by a factor based on the number of

pills actually consumed.?

One would then end up with a truer reflection of the problem.

Seroxat is/was the biggest seller therefore you would expect the crude

totals of drug reactions to be the highest. One would have to factor

in/out the Panorama effect in relation to the obvious spikes in yellow

card activity.

BTW has anyone considered why the Seroxat yellowcard spikes died down

sometime after the Panorama programmes .................like what caused

the reverse awareness?

I'm left wondering how much of this was caused by media hype of one drug

to the detriment of the safety of people who take/took any of the other

7 brands?

What is clear though Jim is that I agree with you that none of them work

& they are all just as likely to kill you as to cure you!

Suspected adverse drug reactions to paroxetine (yellow-card

reports)

per 100 000 paroxetine prescriptions by year and month

between

2001

and 2004. Arrows indicate dates of Panorama programmes

(solid

arrows)

or regulatory communications (dashed arrows)

Br J Clin Pharmacol. 2006 February; 61(2): 224--228.

Published online 2005 October 27. doi:

10.1111/j.1365-2125.2005.02527.

------------------------------------

[Guest guest]

Hi Jim

There is no direct to consumer advertising of prescription medication in the UK of Gt Britain & Northern Ireland. (I live in the North)

I'm not exactly sure if it is allowed in Southern Ireland. Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a scourge I'm not sure we can agree on the success or otherwise of the publicity thus far.

I have no doubt that Panorama has led to a downward pressure on Seroxat but the chart below (from Tuesday's blog) paints a very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the decrease in Seroxat. It is hard to see therefore what good has come out of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to withdraw from) how did all those people actually get off that particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a considerable rump of other brands still on the market with a press firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers ..............will Mark Harvey be liable for the mess he & his cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>> > >>>>>>>> >>>>>>>> >>>>>>>> >>>>>>> Suspected adverse drug reactions to paroxetine (yellow-card> >>>>>>> > >>> reports)> >>> > >>>>>>> per 100 000 paroxetine prescriptions by year and month> >>>>>>> > > between> > > >>> 2001> >>> > >>>>>>> and 2004. Arrows indicate dates of Panorama programmes> >>>>>>> > > (solid> > > >>> arrows)> >>> > >>>>>>> or regulatory communications (dashed arrows)> >>>>>>>> >>>>>>>> >>>>>>> Br J Clin Pharmacol. 2006 February; 61(2): 224--228.> >>>>>>>> >>>>>>> Published online 2005 October 27. doi:> >>>>>>> > >>> 10.1111/j.1365-2125.2005.02527.> >>> > >>>>>>>> >>>>>>> > >>>>>> > >>>>>> >>>>>> >>>>>> >>>>> > >>>> > >>>> >>>> >>>> >>> > >> > >> >> >> >> >> >> >> >> >> >> > ------------------------------------> >> >

[Guest guest]

Hi Jim

There is no direct to consumer advertising of prescription medication in the UK of Gt Britain & Northern Ireland. (I live in the North)

I'm not exactly sure if it is allowed in Southern Ireland. Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a scourge I'm not sure we can agree on the success or otherwise of the publicity thus far.

I have no doubt that Panorama has led to a downward pressure on Seroxat but the chart below (from Tuesday's blog) paints a very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the decrease in Seroxat. It is hard to see therefore what good has come out of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to withdraw from) how did all those people actually get off that particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a considerable rump of other brands still on the market with a press firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers ..............will Mark Harvey be liable for the mess he & his cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>> > >>>>>>>> >>>>>>>> >>>>>>>> >>>>>>> Suspected adverse drug reactions to paroxetine (yellow-card> >>>>>>> > >>> reports)> >>> > >>>>>>> per 100 000 paroxetine prescriptions by year and month> >>>>>>> > > between> > > >>> 2001> >>> > >>>>>>> and 2004. Arrows indicate dates of Panorama programmes> >>>>>>> > > (solid> > > >>> arrows)> >>> > >>>>>>> or regulatory communications (dashed arrows)> >>>>>>>> >>>>>>>> >>>>>>> Br J Clin Pharmacol. 2006 February; 61(2): 224--228.> >>>>>>>> >>>>>>> Published online 2005 October 27. doi:> >>>>>>> > >>> 10.1111/j.1365-2125.2005.02527.> >>> > >>>>>>>> >>>>>>> > >>>>>> > >>>>>> >>>>>> >>>>>> >>>>> > >>>> > >>>> >>>> >>>> >>> > >> > >> >> >> >> >> >> >> >> >> >> > ------------------------------------> >> >

[Guest guest]

Hi Jim

There is no direct to consumer advertising of prescription medication in the UK of Gt Britain & Northern Ireland. (I live in the North)

I'm not exactly sure if it is allowed in Southern Ireland. Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a scourge I'm not sure we can agree on the success or otherwise of the publicity thus far.

I have no doubt that Panorama has led to a downward pressure on Seroxat but the chart below (from Tuesday's blog) paints a very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the decrease in Seroxat. It is hard to see therefore what good has come out of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to withdraw from) how did all those people actually get off that particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a considerable rump of other brands still on the market with a press firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers ..............will Mark Harvey be liable for the mess he & his cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>> > >>>>>>>> >>>>>>>> >>>>>>>> >>>>>>> Suspected adverse drug reactions to paroxetine (yellow-card> >>>>>>> > >>> reports)> >>> > >>>>>>> per 100 000 paroxetine prescriptions by year and month> >>>>>>> > > between> > > >>> 2001> >>> > >>>>>>> and 2004. Arrows indicate dates of Panorama programmes> >>>>>>> > > (solid> > > >>> arrows)> >>> > >>>>>>> or regulatory communications (dashed arrows)> >>>>>>>> >>>>>>>> >>>>>>> Br J Clin Pharmacol. 2006 February; 61(2): 224--228.> >>>>>>>> >>>>>>> Published online 2005 October 27. doi:> >>>>>>> > >>> 10.1111/j.1365-2125.2005.02527.> >>> > >>>>>>>> >>>>>>> > >>>>>> > >>>>>> >>>>>> >>>>>> >>>>> > >>>> > >>>> >>>> >>>> >>> > >> > >> >> >> >> >> >> >> >> >> >> > ------------------------------------> >> >

[Guest guest]

Hi Jim

There is no direct to consumer advertising of prescription medication in the UK of Gt Britain & Northern Ireland. (I live in the North)

I'm not exactly sure if it is allowed in Southern Ireland. Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a scourge I'm not sure we can agree on the success or otherwise of the publicity thus far.

I have no doubt that Panorama has led to a downward pressure on Seroxat but the chart below (from Tuesday's blog) paints a very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the decrease in Seroxat. It is hard to see therefore what good has come out of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to withdraw from) how did all those people actually get off that particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a considerable rump of other brands still on the market with a press firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers ..............will Mark Harvey be liable for the mess he & his cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>> > >>>>>>>> >>>>>>>> >>>>>>>> >>>>>>> Suspected adverse drug reactions to paroxetine (yellow-card> >>>>>>> > >>> reports)> >>> > >>>>>>> per 100 000 paroxetine prescriptions by year and month> >>>>>>> > > between> > > >>> 2001> >>> > >>>>>>> and 2004. Arrows indicate dates of Panorama programmes> >>>>>>> > > (solid> > > >>> arrows)> >>> > >>>>>>> or regulatory communications (dashed arrows)> >>>>>>>> >>>>>>>> >>>>>>> Br J Clin Pharmacol. 2006 February; 61(2): 224--228.> >>>>>>>> >>>>>>> Published online 2005 October 27. doi:> >>>>>>> > >>> 10.1111/j.1365-2125.2005.02527.> >>> > >>>>>>>> >>>>>>> > >>>>>> > >>>>>> >>>>>> >>>>>> >>>>> > >>>> > >>>> >>>> >>>> >>> > >> > >> >> >> >> >> >> >> >> >> >> > ------------------------------------> >> >

[Guest guest]

,

Your right, the bad press for Seroxat only brought the other poisons

more prescriptions.

At the same time we are trying to get truth out the different companies

are in competition

and would just love for a competitor to get bad press to further their

own aims.

The statistics are interesting, the press on Seroxat apparently created

a lull in prescribing

for all the drugs at that time, around the time of the AD warnings by

MHRA also,

so there was a slow down for a while.

http://farm3.static.flickr.com/2774/4311312628_31a1dd6ea2.jpg

It appears that the prescriptions have gone through the roof despite

all efforts.

Didn't MHRA put out warnings ahead of FDA? Seems like the FDA warnings

press

might have had more of an effect that the MHRA warnings.

I think there could be other factors contributing to the increase in

the use of ADs.

I don't know what the other factors are, any ideas?

I know drug companies do surveys, promote in journals, in general work

overtime selling their

products.

I wouldn't discount the bad press on Seroxat as any press against any

of the drugs is better than none.

We are fighting an entrenched treatment model that makes money at the

expense

of the patients and the psychiatrists and doctors groups are not so

much regulated by government

in the USA as they tell the government how it shall be because they are

the "authorities".

We are fighting a PR war, we have truth and pharma has the

"authorities" and industry to prop up

their claims, in the US pharma has DCA also, direct to consumer

advertising, I think New Zealand is the

only other country that allows DCA. Apparently if you say it enough

then it's true!

Propaganda definitely works as we see advertising in the US that lists

ALL the black box warnings and

people still take the bloody drugs. It's an amazing phenomena.

Any press that draws attention to any of the ADs is better than none if

it stops one person from

falling into the trap even if the end result is not a ban on the drugs

it's better than nothing. Even if they

take the drug, have an adverse event and the data is really out there

then they have a chance to figure it

out and protect/save themselves.

When we finally had the warnings in the USA I felt we had won, and yet

the drugs are still on the market,

people are still taking them, doctors are still prescribing them and

companies are getting more and more

of them approved through the corrupted FDA. I would still rather have

the warnings then not so that

people at least have a chance of getting to the truth.

It seems there was a lot of press on horrible antidepressant suicides

and violence in the UK not

long ago, well some years ago now, I remember one where a man soaked

himself with petrol and was found burnt up. I haven't

seen any like that in a while. I know it's still happening.

Best,

Jim

On 2/5/2010 2:42 PM, jeremy9282 wrote:

Hi Jim

There is no direct to consumer advertising of prescription

medication in the UK of Gt Britain & Northern Ireland. (I live in

the North)

I'm not exactly sure if it is allowed in Southern Ireland.

Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a

scourge I'm not sure we can agree on the success or otherwise of the

publicity thus far.

I have no doubt that Panorama has led to a downward pressure on

Seroxat but the chart below (from Tuesday's blog) paints a

very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the

decrease in Seroxat. It is hard to see therefore what good has come out

of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of

the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to

withdraw from) how did all those people actually get off that

particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of

develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a

considerable rump of other brands still on the market with a press

firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers

...............will Mark Harvey be liable for the mess he & his

cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>> Suspected adverse drug reactions to

paroxetine (yellow-card

> >>>>>>>

> >>> reports)

> >>>

> >>>>>>> per 100 000 paroxetine prescriptions

by year and month

> >>>>>>>

> > between

> >

> >>> 2001

> >>>

> >>>>>>> and 2004. Arrows indicate dates of

Panorama programmes

> >>>>>>>

> > (solid

> >

> >>> arrows)

> >>>

> >>>>>>> or regulatory communications (dashed

arrows)

> >>>>>>>

> >>>>>>>

> >>>>>>> Br J Clin Pharmacol. 2006 February;

61(2): 224--228.

> >>>>>>>

> >>>>>>> Published online 2005 October 27. doi:

> >>>>>>>

> >>> 10.1111/j.1365-2125.2005.02527.

> >>>

> >>>>>>>

> >>>>>>>

> >>>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>

> >>>

> >>>

> >>>

> >>>

> >>

> >

> >

> >

> >

> >

> >

> >

> >

> >

> >

> > ------------------------------------

> >

> >

[Guest guest]

,

Your right, the bad press for Seroxat only brought the other poisons

more prescriptions.

At the same time we are trying to get truth out the different companies

are in competition

and would just love for a competitor to get bad press to further their

own aims.

The statistics are interesting, the press on Seroxat apparently created

a lull in prescribing

for all the drugs at that time, around the time of the AD warnings by

MHRA also,

so there was a slow down for a while.

http://farm3.static.flickr.com/2774/4311312628_31a1dd6ea2.jpg

It appears that the prescriptions have gone through the roof despite

all efforts.

Didn't MHRA put out warnings ahead of FDA? Seems like the FDA warnings

press

might have had more of an effect that the MHRA warnings.

I think there could be other factors contributing to the increase in

the use of ADs.

I don't know what the other factors are, any ideas?

I know drug companies do surveys, promote in journals, in general work

overtime selling their

products.

I wouldn't discount the bad press on Seroxat as any press against any

of the drugs is better than none.

We are fighting an entrenched treatment model that makes money at the

expense

of the patients and the psychiatrists and doctors groups are not so

much regulated by government

in the USA as they tell the government how it shall be because they are

the "authorities".

We are fighting a PR war, we have truth and pharma has the

"authorities" and industry to prop up

their claims, in the US pharma has DCA also, direct to consumer

advertising, I think New Zealand is the

only other country that allows DCA. Apparently if you say it enough

then it's true!

Propaganda definitely works as we see advertising in the US that lists

ALL the black box warnings and

people still take the bloody drugs. It's an amazing phenomena.

Any press that draws attention to any of the ADs is better than none if

it stops one person from

falling into the trap even if the end result is not a ban on the drugs

it's better than nothing. Even if they

take the drug, have an adverse event and the data is really out there

then they have a chance to figure it

out and protect/save themselves.

When we finally had the warnings in the USA I felt we had won, and yet

the drugs are still on the market,

people are still taking them, doctors are still prescribing them and

companies are getting more and more

of them approved through the corrupted FDA. I would still rather have

the warnings then not so that

people at least have a chance of getting to the truth.

It seems there was a lot of press on horrible antidepressant suicides

and violence in the UK not

long ago, well some years ago now, I remember one where a man soaked

himself with petrol and was found burnt up. I haven't

seen any like that in a while. I know it's still happening.

Best,

Jim

On 2/5/2010 2:42 PM, jeremy9282 wrote:

Hi Jim

There is no direct to consumer advertising of prescription

medication in the UK of Gt Britain & Northern Ireland. (I live in

the North)

I'm not exactly sure if it is allowed in Southern Ireland.

Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a

scourge I'm not sure we can agree on the success or otherwise of the

publicity thus far.

I have no doubt that Panorama has led to a downward pressure on

Seroxat but the chart below (from Tuesday's blog) paints a

very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the

decrease in Seroxat. It is hard to see therefore what good has come out

of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of

the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to

withdraw from) how did all those people actually get off that

particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of

develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a

considerable rump of other brands still on the market with a press

firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers

...............will Mark Harvey be liable for the mess he & his

cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>> Suspected adverse drug reactions to

paroxetine (yellow-card

> >>>>>>>

> >>> reports)

> >>>

> >>>>>>> per 100 000 paroxetine prescriptions

by year and month

> >>>>>>>

> > between

> >

> >>> 2001

> >>>

> >>>>>>> and 2004. Arrows indicate dates of

Panorama programmes

> >>>>>>>

> > (solid

> >

> >>> arrows)

> >>>

> >>>>>>> or regulatory communications (dashed

arrows)

> >>>>>>>

> >>>>>>>

> >>>>>>> Br J Clin Pharmacol. 2006 February;

61(2): 224--228.

> >>>>>>>

> >>>>>>> Published online 2005 October 27. doi:

> >>>>>>>

> >>> 10.1111/j.1365-2125.2005.02527.

> >>>

> >>>>>>>

> >>>>>>>

> >>>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>

> >>>

> >>>

> >>>

> >>>

> >>

> >

> >

> >

> >

> >

> >

> >

> >

> >

> >

> > ------------------------------------

> >

> >

[Guest guest]

,

Your right, the bad press for Seroxat only brought the other poisons

more prescriptions.

At the same time we are trying to get truth out the different companies

are in competition

and would just love for a competitor to get bad press to further their

own aims.

The statistics are interesting, the press on Seroxat apparently created

a lull in prescribing

for all the drugs at that time, around the time of the AD warnings by

MHRA also,

so there was a slow down for a while.

http://farm3.static.flickr.com/2774/4311312628_31a1dd6ea2.jpg

It appears that the prescriptions have gone through the roof despite

all efforts.

Didn't MHRA put out warnings ahead of FDA? Seems like the FDA warnings

press

might have had more of an effect that the MHRA warnings.

I think there could be other factors contributing to the increase in

the use of ADs.

I don't know what the other factors are, any ideas?

I know drug companies do surveys, promote in journals, in general work

overtime selling their

products.

I wouldn't discount the bad press on Seroxat as any press against any

of the drugs is better than none.

We are fighting an entrenched treatment model that makes money at the

expense

of the patients and the psychiatrists and doctors groups are not so

much regulated by government

in the USA as they tell the government how it shall be because they are

the "authorities".

We are fighting a PR war, we have truth and pharma has the

"authorities" and industry to prop up

their claims, in the US pharma has DCA also, direct to consumer

advertising, I think New Zealand is the

only other country that allows DCA. Apparently if you say it enough

then it's true!

Propaganda definitely works as we see advertising in the US that lists

ALL the black box warnings and

people still take the bloody drugs. It's an amazing phenomena.

Any press that draws attention to any of the ADs is better than none if

it stops one person from

falling into the trap even if the end result is not a ban on the drugs

it's better than nothing. Even if they

take the drug, have an adverse event and the data is really out there

then they have a chance to figure it

out and protect/save themselves.

When we finally had the warnings in the USA I felt we had won, and yet

the drugs are still on the market,

people are still taking them, doctors are still prescribing them and

companies are getting more and more

of them approved through the corrupted FDA. I would still rather have

the warnings then not so that

people at least have a chance of getting to the truth.

It seems there was a lot of press on horrible antidepressant suicides

and violence in the UK not

long ago, well some years ago now, I remember one where a man soaked

himself with petrol and was found burnt up. I haven't

seen any like that in a while. I know it's still happening.

Best,

Jim

On 2/5/2010 2:42 PM, jeremy9282 wrote:

Hi Jim

There is no direct to consumer advertising of prescription

medication in the UK of Gt Britain & Northern Ireland. (I live in

the North)

I'm not exactly sure if it is allowed in Southern Ireland.

Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a

scourge I'm not sure we can agree on the success or otherwise of the

publicity thus far.

I have no doubt that Panorama has led to a downward pressure on

Seroxat but the chart below (from Tuesday's blog) paints a

very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the

decrease in Seroxat. It is hard to see therefore what good has come out

of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of

the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to

withdraw from) how did all those people actually get off that

particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of

develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a

considerable rump of other brands still on the market with a press

firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers

...............will Mark Harvey be liable for the mess he & his

cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>> Suspected adverse drug reactions to

paroxetine (yellow-card

> >>>>>>>

> >>> reports)

> >>>

> >>>>>>> per 100 000 paroxetine prescriptions

by year and month

> >>>>>>>

> > between

> >

> >>> 2001

> >>>

> >>>>>>> and 2004. Arrows indicate dates of

Panorama programmes

> >>>>>>>

> > (solid

> >

> >>> arrows)

> >>>

> >>>>>>> or regulatory communications (dashed

arrows)

> >>>>>>>

> >>>>>>>

> >>>>>>> Br J Clin Pharmacol. 2006 February;

61(2): 224--228.

> >>>>>>>

> >>>>>>> Published online 2005 October 27. doi:

> >>>>>>>

> >>> 10.1111/j.1365-2125.2005.02527.

> >>>

> >>>>>>>

> >>>>>>>

> >>>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>

> >>>

> >>>

> >>>

> >>>

> >>

> >

> >

> >

> >

> >

> >

> >

> >

> >

> >

> > ------------------------------------

> >

> >

[Guest guest]

,

Your right, the bad press for Seroxat only brought the other poisons

more prescriptions.

At the same time we are trying to get truth out the different companies

are in competition

and would just love for a competitor to get bad press to further their

own aims.

The statistics are interesting, the press on Seroxat apparently created

a lull in prescribing

for all the drugs at that time, around the time of the AD warnings by

MHRA also,

so there was a slow down for a while.

http://farm3.static.flickr.com/2774/4311312628_31a1dd6ea2.jpg

It appears that the prescriptions have gone through the roof despite

all efforts.

Didn't MHRA put out warnings ahead of FDA? Seems like the FDA warnings

press

might have had more of an effect that the MHRA warnings.

I think there could be other factors contributing to the increase in

the use of ADs.

I don't know what the other factors are, any ideas?

I know drug companies do surveys, promote in journals, in general work

overtime selling their

products.

I wouldn't discount the bad press on Seroxat as any press against any

of the drugs is better than none.

We are fighting an entrenched treatment model that makes money at the

expense

of the patients and the psychiatrists and doctors groups are not so

much regulated by government

in the USA as they tell the government how it shall be because they are

the "authorities".

We are fighting a PR war, we have truth and pharma has the

"authorities" and industry to prop up

their claims, in the US pharma has DCA also, direct to consumer

advertising, I think New Zealand is the

only other country that allows DCA. Apparently if you say it enough

then it's true!

Propaganda definitely works as we see advertising in the US that lists

ALL the black box warnings and

people still take the bloody drugs. It's an amazing phenomena.

Any press that draws attention to any of the ADs is better than none if

it stops one person from

falling into the trap even if the end result is not a ban on the drugs

it's better than nothing. Even if they

take the drug, have an adverse event and the data is really out there

then they have a chance to figure it

out and protect/save themselves.

When we finally had the warnings in the USA I felt we had won, and yet

the drugs are still on the market,

people are still taking them, doctors are still prescribing them and

companies are getting more and more

of them approved through the corrupted FDA. I would still rather have

the warnings then not so that

people at least have a chance of getting to the truth.

It seems there was a lot of press on horrible antidepressant suicides

and violence in the UK not

long ago, well some years ago now, I remember one where a man soaked

himself with petrol and was found burnt up. I haven't

seen any like that in a while. I know it's still happening.

Best,

Jim

On 2/5/2010 2:42 PM, jeremy9282 wrote:

Hi Jim

There is no direct to consumer advertising of prescription

medication in the UK of Gt Britain & Northern Ireland. (I live in

the North)

I'm not exactly sure if it is allowed in Southern Ireland.

Perhaps Steph Gatchel could clarify?

Whilst it is clear we can agree that psychiatric medication is a

scourge I'm not sure we can agree on the success or otherwise of the

publicity thus far.

I have no doubt that Panorama has led to a downward pressure on

Seroxat but the chart below (from Tuesday's blog) paints a

very worrisome picture !

The rate of increase of all brands of SSRI's far exceed the

decrease in Seroxat. It is hard to see therefore what good has come out

of the publicity & /or any regulatory action thus far.

The question remains to be explained that if the broad thrust of

the Seroxat litigation is to be studied (i.e. Seroxat is the hardest to

withdraw from) how did all those people actually get off that

particular drug?

http://www.tuesday1st.blogspot.com/

Todays news is interesting .........it seems GSK is pulling out of

develpopment of any new antidepressants.

What on earth is going to happen, we will be left with a

considerable rump of other brands still on the market with a press

firmly of the position that Seroxat was the worst, so good riddance.

Sadly the UK press was bought by the Litigation lawyers

...............will Mark Harvey be liable for the mess he & his

cohorts leave behind when they leave the field in the next few months?

Food for thought

(SSRI Crusaders will continue to speak out about all psych drugs)

> >>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>>

> >>>>>>> Suspected adverse drug reactions to

paroxetine (yellow-card

> >>>>>>>

> >>> reports)

> >>>

> >>>>>>> per 100 000 paroxetine prescriptions

by year and month

> >>>>>>>

> > between

> >

> >>> 2001

> >>>

> >>>>>>> and 2004. Arrows indicate dates of

Panorama programmes

> >>>>>>>

> > (solid

> >

> >>> arrows)

> >>>

> >>>>>>> or regulatory communications (dashed

arrows)

> >>>>>>>

> >>>>>>>

> >>>>>>> Br J Clin Pharmacol. 2006 February;

61(2): 224--228.

> >>>>>>>

> >>>>>>> Published online 2005 October 27. doi:

> >>>>>>>

> >>> 10.1111/j.1365-2125.2005.02527.

> >>>

> >>>>>>>

> >>>>>>>

> >>>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>>

> >>>>

> >>>

> >>>

> >>>

> >>>

> >>

> >

> >

> >

> >

> >

> >

> >

> >

> >

> >

> > ------------------------------------

> >

> >